Korro Bio, Inc. Severance Costs
Korro Bio, Inc. (KRRO) reported Severance Costs of $3.84 million for the 12-month period ending 2023-12-31, per its 10-Q filed 2023-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2023-11-02
- Korro Bio, Inc. severance costs for the quarter ending 2023-12-31 was $0.00.
- Korro Bio, Inc. severance costs for the quarter ending 2023-09-30 was $0.00.
- Korro Bio, Inc. severance costs for the quarter ending 2023-06-30 was $359.00K.
- Korro Bio, Inc. severance costs for the quarter ending 2023-03-31 was $3.48M.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $359.00K derived: sum of 3 quarters · filed 2023-11-02 | $3.84M 10-Q · filed 2023-05-12 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $359.00K derived: sum of 2 quarters · filed 2023-11-02 | $3.84M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $359.00K 10-Q · filed 2023-05-12 | $3.84M 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $3.48M 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |